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ABSTRACT
LncRNAs (Long noncoding RNAs) are novel group of ncRNAs and has been discovered to be pervasively transcripted in 
the genome, characterized as endogenous cellular RNAs consist of more than 200 nucleotides. They are ordered in view 
of function, transcript length, relation with protein-coding genes and other functional DNA elements, and subcellular 
localization. Theranostics is a novel study in medicine that combines specific targeted biomolecules based upon 
molecular-based test. As novel finding in the field of molecular medicine, lncRNA is indispensable tools in theranostics 
based medicine that allows specific targeting of molecular pathway for diagnostics and therapeutics. LncRNAs may 
execute as signals, decoys, guides, and scaffolds in their natural capacities. LncRNA expression is controlled by 
transcriptional and epigenetic factors and processes. LncRNAs also relate detracting biological programs. Here we 
reviewed lncRNAs in disorders/diseasest horoughly based on CONDBITs perspectives, i.e.: cardiology, oncology, neurology 
and neuroscience, dermatology, the biology of molecular and bioinformatics, immunology, and technologies (related 
with “-omics”; transcriptomics and “nano”; nanotechnology). It was narrated the lncRNA biomarkers that abundant 
in cardiovascular, neurodegenerative, dermatology, and immunology perspective. However, as cancer is the most widely 
studied disease, more biomarkers are available for this particular case. There are abundant cancer-associated lncRNAs. 
The most frequent learned lncRNA molecules in cancer are HOTAIR, MALAT1, LincRNA-p21, H19, GAS5, ANRIL, MEG3, 
XIST, HULC. LncRNAs in cancer diagnosis and monitoring, e.g.: H19 and AA174084 (gastric), HULC (hepatocellular), 
PCA3 (prostate). Prognostic lncRNAs, e.g.: HOTAIR and NKILA (breast), MEG3 (meningioma), NBAT-1 (neuroblastoma), 
SCHLAP1 (prostate). LncRNAs predicting therapeutic responsiveness, e.g.: CCAT1 (colorectal), HOTAIR (ovarian). Thus, 
it is concluded that the CONDBIT perspective is useful to describe the encouraging outlook of this transcriptomics-based 
medicinal approach. 
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ABSTRAK
LncRNAs (Long noncoding RNAs) ialah kumpulan ncRNA yang novel dan banyak ditranskripsikan daripada genom 
serta dicirikan sebagai RNA endogen yang mengandungi lebih daripada 200 nukleotida dalam sel. Spesies RNA tersebut 
adalah terkawal dari segi fungsi, panjang transkrip, hubungan dengan gen yang mengekodkan protein dan unsur DNA 
lain yang berfungsi serta lokasi dalam bahagian subsel. Theranostik pula merupakan bidang kajian yang novel dalam 
perubatan yang menggabungkan biomolekul sasaran khusus berdasarkan ujian molekul. Sebagai penemuan baru dalam 
bidang perubatan molekul, lncRNA merupakan molekul sasaran dalam bidang perubatan theranostik yang membolehkan 
penemuan tapak jalan molekul yang spesifik untuk tujuan diagnostik dan terapeutik. LncRNAs dapat bertindak sebagai 
molekul isyarat, umpan, pandu dan perancah secara semula jadi. Pengekspresan LncRNA adalah di bawah kawalan 
tranksripsi dan faktor serta proses epigenetik. LncRNAs juga menghubungkaitkan program biologi. Di sini, kami mengulas 
kefungsian lncRNAs dalam penyakit kegagalan secara terperinci dari perspektif CONDBITs iaitu kardiologi, onkologi, 
neurologi and neurosains, dermatologi, biologi molekul and bioinformasi, imunologi, dan teknologi (berkenaan dengan 
“-omik”; transkriptomik dan “nano”; nanoteknologi). Penanda biologi lncRNA dilaporkan banyak terdapat dalam 
perspektif kardiovaskular, neurodegeneratif, dermatologi, and imunologi. Kanser sebagai penyakit yang telah banyak 
dikaji, semakin banyak penanda biologi telah ditemukan untuk penyakit ini. Terdapat banyak lncRNAs yang berkait 
rapat dengan kanser. Antara yang kerap dikaji adalah HOTAIR, MALAT1, LincRNA-p21, H19, GAS5, ANRIL, MEG3, XIST, 
HULC. LncRNAs yang banyak digunakan untuk diagnosis dan pengawasan kanser adalah seperti H19 and AA174084 
(gastrik), HULC (hepatoselular), PCA3 (prostat). LncRNAs prognostik pula termasuk HOTAIR and NKILA (payu dara), 
MEG3 (meningioma), NBAT-1 (neuroblastoma), SCHLAP1 (prostat). LncRNAs yang digunakan untuk menjangka tindak 
balas terhadap rawatan adalah seperti CCAT1 (colorectal), HOTAIR (ovarian). Oleh itu, perspektif CONDBIT adalah sangat 
berguna untuk memerihalkan pendekatan yang berdasarkan transkriptomik.
Kata kunci: LncRNAs; perspektif CONDBITs; penanda penyakit; bioinformasi; theranostik
2INTRODUCTION
LNCRNA ANNOTATION
LncRNAs (Long noncoding RNAs) are novel group 
of ncRNAs and has been discovered to be pervasively 
transcripted in the genome, characterized as endogenous 
cellular RNAs consist of more than 200 nucleotides 
(Mattick & Rinn 2015; Amaral & Mattick 2008). They have 
several general basic attributes, such as elective splicing, 
polyadenylation, low abundance, deficiency of protein 
product, and low sequence identity. They constitute a very 
heterogeneous group of RNA molecules that permits them 
to cover an expansive range of molecular-cellular functions 
by actualizing different modes of activity. They are ordered 
in view of function, transcript length, relation with protein-
coding genes and other functional DNA elements, and 
subcellular localization.
LncRNAs may execute as signals, decoys, guides, 
and scaffolds in their natural capacities (Iwakiri, Hamada 
& Asai 2016). LncRNAs assume an imperative part in 
controlling gene expression at diversified levels, including 
chromatin alteration, transcriptional and posttranscriptional 
regulation, through multiple pathways that involve interplay 
with RNA binding proteins, subduing a major promoter 
of their aim gene, or performing as a co-activator of 
transcription factors (Sun et al. 2015). LncRNA expression 
is controlled by transcriptional and epigenetic factors and 
processes. LncRNAs also relate detracting biological 
programs (growth and development, the formation of 
cell identity, distribution of stress responses). There are 
32,183 human annotated lncRNAs based on LNCipedia 
2.0. Another study distinguished 6,736 lncRNA genes 
in the human genome (Devaux et al. 2015). In this end, 
lncRNA could be found on every manifestation of maladies 
in human. Moreover, the importance of lncRNA studies 
should be stated on every discussion on the molecular 
mechanism of the diseases. LncRNA is an indispensable 
aspect of theranostics-based therapy and diagnostics 
because it is only targeting specific molecular mechanism 
in the cell, in particular the transcriptomics pathway. 
CARDIOVASCULAR PERSPECTIVE
LncRNAs have risen as critical regulators of cardiovascular 
development. LncRNAs control the differentiation of 
pluripotent stem cells and cardiac precursors into functional 
adult cardiac cells in the early phase of life. Afterward, they 
regulate cellular senescence and many pathways required 
in cardiovascular disorders (Devaux et al. 2015). 
LncRNAs KCNQ1OT1 (class antisense, species 
human, chromosome 11) has important roles in arrhythmia 
and cardiac development(Korostowski, Sedlak, and Engel 
2012; Bokil et al. 2010). LncRNAs Ak011347, Bvht, Fendrr 
(class intergenic, species mouse) have also the important 
role in cardiac development (Klattenhoff et al. 2013; J. G. 
Zhu et al. 2014; Grote et al. 2013).
Additionally, lncRNAs have an imperative part 
of heart development. A novel lncRNA Braveheart 
(AK143260) required for specification of the cardiac 
lineage in vitro. Depletion of lncRNA (AK143260) causes 
loss of beating cardiomyocytes during embryonic stem 
cell differentiation and an inability to initiate a network 
of genes specifying key cardiac transcription factors 
and myofibril assembly components. This lncRNA is 
needed for interceding the transition from mesoderm to 
multipotent cardiac progenitors (Schonrock, Harvey & 
Mattick 2012).
Another class of lncRNAs, i.e. SRA transcripts, have 
a critical capacity as coactivators of nuclear receptor 
signaling, muscle differentiation, and components of gene 
insulator complexes. It is also connected with dilated 
cardiomyopathy (Friedrichs et al. 2009). One of lncRNA, 
namely ALC-1 antisense, from class NAT (natural antisense 
transcript) has a vital role in the regulation of ALC-1. It 
has a noteworthy association while induced in hypertrophic 
ventricles (Ritter et al. 1999). Inhibition of MALAT1 
in vivo by oligonucleotides diminished vascularization, 
indicating MALAT1 as an intriguing target to control 
angiogenic processes (Michalik et al. 2014).
Myocardial infarction associated transcript (MIAT) 
was identified as lncRNA which before 2006 also known 
as GOMAFU, AK028326, RNCR2. It is a non-coding RNA 
that has a pathobiological role in the cardiovascular system. 
MIAT dysregulation has a critical impact on the pathogenesis 
of MI and atherosclerosis, as well as another microvascular 
dysfunction, via enigmatic pathways (Yan et al. 2015; Liao 
et al. 2016; Vausort, Wagner & Devaux 2014). 
HEART FAILURE
Long non-coding RNAs (lncRNAs) also play an important 
role in heart failure (El Azzouzi, Doevendans & Sluijter 
2016). Some lncRNAs have been observed to be changed in 
the developing or diseased heart, several single nucleotide 
polymorphisms (SNP) in lncRNAs have appeared to be 
emphatically correlated with cardiovascular disease. 
For instance, SNPs in myocardial infarction associated 
transcript (MIAT) and antisense non-coding RNA in the 
INK4 locus (ANRIL) will forecast the increased risk of 
cardiovascular disease (Carlock et al. 1985; Ishii et al. 
2006). In addition, lncRNA H19 was fundamentally 
upregulated in fizzling murine hearts, indicating a role for 
hypoxia-regulated lncRNA expression in heart failure (Lee 
et al. 2011; Yang et al. 2014). LncRNA MT-LIPCAR (human 
species, chromosome M) can predict survival in patients 
with heart failure (Kumarswamy et al. 2014).
Actually, lncRNA levels not only responded more 
sensitively to LVAD (left ventricular assist device) support 
but their expression profile permitted to recognize left 
ventricular samples from patients with ischemic and 
nonischemic heart failure before and after LVAD support 
(Consortium et al. 2013; Samani et al. 2007).
3There are some LncRNAs with potential biomarker 
applications. CDKN2BAS1 (ANRIL) can be utilized as 
a risk factor biomarker for coronary artery disease and 
myocardial infarction. MIAT can be used as a risk factor 
biomarker for myocardial infarction (Ishii et al. 2006).
ONCOLOGY PERSPECTIVE
There are abundant lncRNAs associated with cancer, such 
as APL or acute promyelocytic leukemia (NEAT1), bladder 
cancer (GHET1, Linc-UBC1, H19, MALAT1, MEG3, 
SNHG16, TUG1, UCA1), breast cancer (ANRIL, BC040587, 
BCAR4, BCYRN1, DSCAM-AS1, GAS5, H19, HOTAIR, 
HOTAIRM1, IRAIN, LincRNA-BC4, LincRNA-BC5, 
Loc554202, LSINCT5, MALAT1, MEG3, MIR31HG, 
PINC, PVT1, SRA1, XIST, ZNFX1-AS1), cervical cancer 
(HOTAIR, GAS5), colorectal cancer (CASC2, CCAT1, 
CRNDE, GAS5, HULC, HOTAIR, KCNQ1OT, lncRNA-422, 
LincRNA-p21, Lnc-LET, MALAT1, NR_015441, 
NR_033374, R05532, SNGH16), endometrial carcinoma 
(CASC2, HOTAIR, MALAT1), epithelial squamous 
cell carcinoma or ESCC (Taurine-upregulated gene 1 or 
TUG1, lincPOU3F3), gallbladder cancer (lncRNA-LET), 
gastric cancer (LINC00152, GAPLINC, PVT1, HOTAIR, 
FENDRR, AC138128.1, BRAF-activated non-coding RNA 
or BANCR), glioma (HOTAIR, uc.283plus, lincPOU3F3), 
hepatocellular carcinoma (UFC1, MT1DP, lncRNA-LET), 
leukemia (ANRIL, DLEU1, DLEU2, MEG3, MIR155HG, 
TCL6, WT1-AS), melanoma (ANRIL, BANCR, C9orf14, 
SPRY4-IT1), multiple myeloma (MALAT1), non-Hodgkin 
lymphoma (BIC), NSCLC or non-small cell lung carcinoma 
(RP11385J1.2, TUBA4B, PVT1, HOTAIR, MALAT1, 
CARLo5), osteosarcoma (MALAT1, BC040587), ovarian 
cancer (HOST2), pancreatic cancer (BC008363, DAPK, 
HOTAIR, HULC, MALAT1, MAP3K14, PPP3CB, PVT1), 
prostate cancer (C20orf166AS1, CBR3-AS1, CTBP1-AS, 
ENSG00000261777, GAS5, H19, MALAT1, NEAT1, 
PCA3, PCAT1, PCGEM1, PRNCR1, PTENP1, RP11-
267A15.1, ucRNAs, XIST), thyroid carcinoma/cancer 
(AK023948, BANCR, NAMA, PTCSC3) (Eis et al. 2005; 
Isin & Dalay 2015; R. Zhang et al. 2016).
There are a lot of new lncRNA transcripts dysregulated 
in ccRCC (clear cell renal cell carcinoma) that is benefit for 
novel diagnostic biomarkers. The expression of lncRNAs 
was successfully validated for upregulated or highly 
overexpressed in ccRCC (lnc-BMP2-2, lnc-CPN2-1, lnc-
FZD1-2, lnc-ITPR2-3, lnc-SLC30A4-1, lnc-SPAM1-6), 
downregulated (lnc-ACACA-1, lnc-FOXG1-2, lnc-
LCP2-2, lnc-RP3-368B9, lnc-TTC34-3), and unregulated 
(lnc-ERCC5-1, lnc-RP11-480I12.4.1-1) transcripts using 
qPCR. Another lncRNAs in ccRCC are MALAT1, SPRY4-
IT1 (Gutschner & Diederichs 2012; Zhang et al. 2016; 
Blondeau et al. 2015).
Some lncRNAs are overexpressed or decreased in 
multiple human cancer. ANRIL (antisense non-coding 
RNA in the INK4 locus) is positively correlated with 
poor prognosis and considered as a risk factor in 
various types of human cancers, such as breast cancer, 
esophageal squamous cell carcinoma, gastric cancer, 
hepatocellular carcinoma, lung cancer, and ovarian 
cancer (Hua et al. 2015). BANCR (BRAF-activated non-
coding RNA) is abundant in some types of human cancer, 
i.e. colorectal cancer, papillary thyroid carcinoma, 
malignant melanoma (Li et al. 2015). HOTAIR (HOX 
antisense intergenic RNA) is a key regulator of chromatin 
dynamics and gene regulation (Bhan & Mandal 2015). 
It appears to be disrupted in some cancers and diseases. 
It was downregulated in ependymomas and aortic valve 
calcification. It was upregulated in various carcinomas 
i.e. ATRTs (atypical teratoid rhabdoid tumors) such as 
medulloblastomas, and juvenile pilocytic astrocytomas. 
Breast cancer, cervical tumors/cancers, colorectal 
carcinomas, endometrial tumors/carcinomas, esophageal 
squamous cell carcinoma (ESCC), gall bladder cancers, 
gastric cancers, gastrointestinal stromal tumors/cancers, 
gliomas, hepatocellular carcinoma, laryngeal squamous 
cell cancer, melanoma, nasopharyngeal carcinoma, 
nonfunctional pituitary adenoma, non-small cell lung 
cancer, prostate cancer, ovarian cancers, pancreatic 
tumors/cancers, renal carcinomas, sarcoma, small cell 
lung cancer, Ta/T1 bladder cancer, urothelial carcinoma, 
also upregulated in osteoarthritis and pre-eclampsia (Hua 
et al. 2015; Qiu et al. 2015; Bhan & Mandal 2015; Hajjari 
& Salavaty 2015; Huang et al. 2014; Li et al. 2015). Some 
of lncRNAs are elucidated in Table 1 below.
NEURODEGENERATIVE PERSPECTIVE
There are a lot of long ncRNAs involved in neurological 
disorders. They are ANRIL, BDNF-AS, ncRNA-a, Evf-2, 
HTTAS_v1, SCAANT1, 116HG, ATXN8OS, 17A, Gomafu, 
BACE1-AS, BC200, Antisense Uchl1, HAR1F, HAR1R, etc. 
ANRIL which do regulate transcription has INK4b/ARF/
INK4a locus as a target and associated with neural system 
tumors. Long ncRNAs that regulating transcription are 
BDNF-AS, ncRNA-a, Evf-2, HTTAS_v1, SCAANT1, 116HG. 
Long ncRNAs that regulating mRNA processing are 
ATXN8OS, 17A, Gomafu. Long ncRNAs that regulating 
translation are BC200 and antisense Uchl1. BACE1-AS 
regulates mRNA stability and has an important role 
in pathophysiologic of Alzheimer’s disease (AD). The 
other lncRNAs that involved in AD are 17A and BC200. 
ncRNA-a involved in Opitz–Kaveggia syndrome. Evf-2 
that has Dlx5/6 as its target may have roles in many 
neurological disorders, such as autism, epilepsy, Rett-
syndrome, schizophrenia, etc. SCAANT1 has Ataxin 7 as a 
target and involved in Spinocerebellar ataxia 7. ATXN8OS 
has MBLN1 as the target and involved in Spinocerebellar 
ataxia 8. 116HG upregulates many genes as the target 
and involved in Prader–Willi syndrome. Gomafu has 
DISC1 and ERBB4 as targets and involved in schizophrenia, 
mainly associated with behavioral abnormalities. Antisense 
4TABLE 1. Some cancer associated LncRNAs
 No. LncRNA Type of Cancer References
 1. ANRIL basal cell carcinoma, bladder cancer, (Cunnington et al. 2010;
  (antisense non-coding RNA  melanomas, neurofibromas Zhu et al. 2015; Stacey et al. 2009;
  in the INK4 locus) DD3/PCA3  Pasmant et al. 2011)
 2. DD3/PCA3 Prostate cancer (Bussemakers et al. 1999;   
    Durand et al. 2012; Ploussard et al. 2011)
 3. GAS5 (growth arrest-specific Renal cell carcinoma (RCC) (Qiao et al. 2013)
  transcript 5)
 4. H19 Kidney cancer (Frevel et al. 1999)
 5. HIF-1alpha-AS1 and AS2 Kidney cancer (Thrash-Bingham & Tartof 1999; 
    Bertozzi et al. 2011)
 6. HOTAIR Several cancer; i.e.: breast, (Gupta et al. 2010; Kogo et al. 2011;
    colon, liver, and pancreas  Geng et al. 2011; Kim et al. 2013)
 7. HULC (highly upregulated  Hepatocellular carcinoma (Panzitt et al. 2007)
  in liver cancer) 
 8. LncTCF7 Liver CSCs (Cancer Stem Cells) (Wang et al. 2015)
 9. MALAT-1 Small cell lung cancer (Gutschner et al. 2013)
 10. MEG3 (GTL1) Renal cell carcinoma (RCC) (Kawakami et al. 2006)
Uchl1 has UCHL1 as its target and involved in Parkinson’s 
disease (PD). There are minimally eight known lncRNAs 
that were observed to change significantly in the brains of 
Huntington’s disease (HD) patients: TUG1 and NEAT1 are 
upregulated, MEG3 and DGCR5 are downregulated, while 
HTTAS_v1 and BDNF-AS are transcriptionally regulated. 
Another lncRNAs involved in Person with HD are HAR1F 
and HAR1R (Vučićević, Schrewe & Orom 2014; Pollard 
et al. 2006).
Herein the Table 2 some of specific long ncRNAs 
as hallmarks in many neurological problems and 
neurodegenerative diseases and disorders.
TABLE 2. Specific lncRNA in neurological problem
 No. Diseases / disorders LncRNA References
 1. Alzheimer’s disease (AD) beta-site amyloid precursor protein (Luo & Chen 2016; Decourt 
   cleaving enzyme-1 antisense  & Sabbagh 2011; Evin & Hince 2013;  
   transcript (BACE1-AS) Faghihi et al. 2008)
 2. Alzheimer’s disease (AD) 51A (Ciarlo et al. 2013; Ma et al. 2009)
 3. Alzheimer’s disease (AD) 17A (Wan, Su & Zhuo 2017; 
    Massone et al. 2011)
 4. Alzheimer’s disease (AD) neuroblastoma differentiation marker (Massone et al. 2012)
   29 (NDM29)
 5. Alzheimer’s disease (AD) BC200 (brain cytoplasmic 200 RNA) (Mus, Hof & Tiedge 2007)
 6. Alzheimer’s disease (AD) brain cytoplasmic (BC) RNA BCYRN1 (Mus, Hof & Tiedge 2007; 
    Lukiw et al. 1992)
 7. Alzheimer’s disease (AD) NAT-Rad18 (Zlatanou et al. 2016; Parenti et al. 2007)
 8. Amyotrophic lateral sclerosis  AS C9ORF72 (chromosome 9 ORF 72) (Renton et al. 2011; Zu et al. 2013; 
  (ALS)  Lagier-Tourenne et al. 2013)
 9. Autistic spectrum disorder MSNP1AS (moesin pseudogene 1, antisense) (Wilkinson & Campbell 2013; 
  (ASD)  Kerin et al. 2012)
 10. Glioblastoma (GBM) There are 104 matched lncRNA-mRNA (Han et al. 2012)
   pairs for 91 differentially expressed lncRNAs 
   In the GBM group, 654 lncRNAs were 
   downregulated and 654 were upregulated
 11. Huntington’s disease (HD) MEG3 (Zhao et al. 2010)
 12. Huntington’s disease (HD) TUG1 (Khalil et al. 2009)
 13. Huntington’s disease (HD) NEAT1 (Nuclear enriched abundant transcript) (Johnson 2012)
 14. Parkinson’s disease (PD) PINK1-AS (phosphatase and tensin homologue– (Scheele et al. 2007)
   induced kinase 1) 
 15. Parkinson’s disease (PD) AS Uchl1 (Carrieri et al. 2015)
 16. Spinocerebellar Ataxia ATXN8OS (Chen et al. 2008)
 17. Spinocerebellar Ataxia ATXN7L3B (Munhoz et al. 2009)
5DERMATOLOGY PERSPECTIVES
Long noncoding RNA has promising impacts and roles in 
dermatology problems, including melanoma, psoriasis, 
keratinization, and Cutaneous Squamous Cell Carcinoma 
(cSCC). Herein we decipher them concisely. 
MELANOMA
The lncRNA SPRIGHTLY (also known as SPRY4-IT1) is 
upregulated in human melanoma cells. It lies within the 
intronic region of SPRY4 gene. SPRIGHTLY is transcribed 
from the first intron of SPRY4 (Sprouty 4 gene). In human 
melanoma cells, it is highly upregulated. In normal human 
melanocytes, it is ectopically expressed at low levels. It 
contributes to the regulation of DNA damage response, 
chromosome organization, cell proliferation, cell cycle, and 
apoptosis in melanocytes. It also regulates proliferation, 
motility, and apoptosis that constitute cancer hallmarks. 
Together with its target genes, SPRIGHTLY has an impact 
in melanocyte dedifferentiation and their transformation 
into melanomas. It has a lot of important roles in multiple 
regulatory pathways in melanomas. Its dysfunction in 
melanoma cells prohibits cell growth, differentiation, and 
induced apoptosis (Khaitan et al. 2011; Zhao et al. 2016; 
Mazar et al. 2010, 2014). 
Long noncoding RNAs involved in the synthesis 
of melanin. LncRNA-H19 has an important role in the 
formation of melasma. Irradiation of melanocytes with 20 
mJ/cm2 UVB changed expression 807 lncRNAs more than 
two-fold using Agilent lncRNA chip expression profile 
detection technology. LncRNAs involve in the UVB-induced 
stress response. Some lncRNAs expression alterations 
triggered by UVB are dependent on ROS generation. ROS-
mediated production of lnc-CD1D-2:1 participated in the 
UVB-induced melanogenesis. MAPK signaling pathway was 
engaged in the melanogenesis, therefore p38, ERK, and JNK 
phosphorylation levels were observed. The UVB-induced 
alterations in lncRNAs involve in the etiopathogenesis of 
melanoma. LncRNAUCA1 was engaged in H2O2-induced 
cell apoptosis, signifying relationship between ROS and 
lncRNAs (Kim, Lee & Lee 2010; Kim et al. 2014; Peng 
et al. 2014; Liu et al. 2015; Zeng et al. 2016).
Targeting a lncRNA in vivo is a potentially putative 
therapeutic choice, such as SAMMSON (previously known 
as LINC01212). SAMMSON lncRNA plays important roles 
in melanoma development. It is arranged by an alternative 
SOX factor such as SOX9, understood as a key antagonistic 
role to SOX10 in melanoma. It is detectable in melanocytes 
or non-invasive vertical growth phase melanomas, in 
invasive vertical growth phase melanoma, and in migratory 
melanoblasts (Shakhova et al. 2015; Goding 2016; Leucci 
et al. 2016; Hoek & Goding 2010).
SAMMSON confers a growth advantage on melanoma 
cells. Targeting SAMMSON for degradation reduced 
clonogenicity, irrespective of BRAF, NRAS, or p53 
status, including in cell lines exhibiting BRAF inhibitor 
resistance, but did not affect melanocytes, highlighting 
the ‘‘addiction’’ of melanomas to SAMMSON expression. 
It also reduced viability/growth of invasive melanoma 
cells, known to exhibit increased resistance to MAPK 
therapeutics. Importantly, ectopic expression of SAMMSON 
in melanoma cells conferred a growth advantage, indicating 
that SAMMSON acts in trans, an observation consistent with 
the lack of effect on MITF expression following SAMMSON 
knockdown (Shakhova et al. 2015; Goding 2016; Leucci 
et al. 2016; Hoek & Goding 2010) .
Deciphering SAMMSON lncRNA biogenesis, we can 
understand how the MITF amplicon impacts melanoma 
proliferation. MITF (microphthalmia-associated transcription 
factor) is a microenvironmental hallmark of melanoma. It 
is required for melanoblast survival while development, 
melanocyte differentiation, suppresses invasion, promotes 
proliferation, and drives “phenotype switching” which 
props melanoma development (Shakhova et al. 2015; 
Goding 2016; Leucci et al. 2016; Hoek & Goding 2010).
The SAMMSON lncRNA gene is co-amplified with 
MITF in melanoma. SAMMSON-p32 complex is needed for 
correct mitochondrial biogenesis. Depletion of SAMMSON 
leads to stress connected accumulation of mitochondrial 
peptide precursors, mitochondrial import defects, and 
p53-independent apoptosis. BRAF inhibitors (BRAFi) boost 
dependency on mitochondrial oxidative phosphorylation 
and collaborate with SAMMSON inhibition (Shakhova et al. 
2015; Goding 2016; Leucci et al. 2016; Hoek & Goding 
2010).
PSORIASIS
There are 971 lncRNAs were statistically significant 
expressed in psoriasis patients, which whom 399 were 
underexpressed whereas 572 were overexpressed. Some 
of them show decreased expression in psoriasis person, 
such as LOC285194, Car Intergenic 10, ST7OT. Of 
overexpressed 572 lncRNAs, CARD14 lncRNA was 
significantly overexpressed. Mutations in CARD14 
genes are related to susceptibility to psoriasis (Gupta 
et al. 2016).
KERATINIZATION
Long ncRNAs was performed by transcriptome sequencing 
of keratinocytes. The keratinocytes sampled were derived 
from palmar and forearm skin. This research had been 
identified 125 candidate lncRNAs which is involved in 
keratinization (Nomura 2016).
6CUTANEOUS SQUAMOUS CELL CARCINOMA
PICSAR is lncRNA that has an important role in Cutaneous 
Squamous Cell Carcinoma (cSCC) progression. LncRNA 
PICSAR is overexpressed in cSCC cells, both in vivo and 
in culture. It regulates both proliferation and migration of 
cSCC cells and growth of cSCCs cells in vivo. It increases 
the activity of ERK1/2 pathway through inhibition of 
MAPK phosphatase DUSP6. PICSAR is a putative biomarker 
and futuristic therapeutic target in cSCC management 
(Piipponen et al. 2016).
IMMUNOLOGY PERSPECTIVE
Long noncoding RNAs (lncRNAs) have been appeared to 
assume imperative parts in immune cells responses and 
developments via various mechanisms. They have been 
observed to control transcriptional or post-transcriptional 
regulation of innate and adaptive immune responses 
through novel methods for blending with RNA and DNA 
or protein-protein interactions (Zhang & Cao 2016).
Some lncRNAs are involved in immune cell 
development processes, such as immune cell activation, 
differentiation, proliferation. They are NRON, lnc-DC, 
NTT, GAS5, HOTAIRM1, etc (Zhang & Cao 2016).
LncRNAs control the innate immune responses. 
Numerous lncRNAs that have been connected to innate 
immunity have been found by RNA-Seq studies and 
microarray, i.e.: Lethe, NEAT1, NKILA, PACER, and THRIL 
(Table 3), that represent the magnificent patterns of 
lncRNAs that are ensnared in regulating immune cells 
functions and immune genes expressions (Guttman et al. 
2009; Carpenter & Fitzgerald 2015; Imamura & Akimitsu 
2014; Li & Rana 2014).
TECHNOLOGY PERSPECTIVES
The genome annotation technology is necessary to provide 
database management for transcriptomics data (Parikesit 
et al. 2014). In this respect, the gene prediction pipeline 
is important to annotate the missing information in the 
genomes (Goel, Singh & Aseri 2013). This pipeline is 
TABLE 3. The roles of lncRNAs in innate immune responses
 No. lncRNA References
 1. Lethe (Zgheib et al. 2017; Rapicavoli et al. 2013)
 2. NEAT1 (Imamura et al. 2014; Hirose et al. 2014)
 3. NKILA (NF-KappaB interacting lncRNA) (Huang et al. 2016)
 4. PACER (p50-associated COX-2 extragenic RNA) (Krawczyk & Emerson 2014; Cui et al. 2014; Qian et al. 2016) 
 5. THRIL (linc1992) (Szmyrka-Kaczmarek et al. 2014; Li et al. 2014)
AUTOIMMUNE DISEASES AND LNCRNA
Autoimmune diseases are complicated and enigmatic 
diseases resulting from the interaction between 
genetics, epigenetics, and environmental factors (Wu 
et al. 2015). LncRNAs dysregulation regulate certain 
mechanisms in autoimmune diseases, including PRINS 
(10p12.1) arranges G1P3 to maintain the keratinocyte 
hyperproliferation in psoriasis (Szegedi et al. 2012, 
2010). Dysregulation of lncRNAs influences various 
autoimmune diseases. For further explanation, we 
elucidate in the Table 4 herein.
TABLE 4. Autoimmune diseases and lncRNA Narration
 No.     Diseases             References
 1. Psoriasis Vulgaris (PV) (Szegedi et al. 2012, 2010; Sonkoly et al. 2005; Bari et al. 2011; 
   Chang et al. 2006; Holm et al. 2005) 
 2. Systemic lupus erythematosus (SLE) (Cope & Feldmann 2004; Chatenoud 2006; Shi et al. 2014; Giles, 
   Nycz & Boackle 2016) 
 3. Rheumatoid arthritis (RA) (Song et al. 2014; Messemaker et al. 2016;  Lu et al. 2016) 
especially crucial in annotating the transcriptomics data 
that still currently lacking information. Problem arises, as 
the generated data will be grown exponentially, in the scale 
of petabytes. Thus, the data mining method for big data 
storage is very feasible to be applied on daily basis in order 
to extract for definite transcriptomics pattern (Ranganathan 
et al. 2011). This hunt for information could only be 
7TABLE 5. The database for lncRNA research (Based on our exploration)
 No.                  Database                                 Website
 1. CHIPBase  deepbase.sysu.edu.cn/chipbase
 2. DIANA-LncBase diana.imis.athena-innovation.gr
 3. fRNAdb  www.Ncrna.org/frnadb
 4. Human Body Map lincRNAs  www.Broadinstitute.org/genome bio/human lincrnas
 5. LNCipedia www.lncipedia.org
 6. lncRNAdb  www.lncrnadb.org
 7. lncRNAdb Expert Database http://rnacentral.org/expert-database/lncrnadb
 8. lncRNADisease cmbi.bjmu.edu.cn/lncrnadisease
 9. LncRNADisease database http://www.cuilab.cn/lncrnadisease
 10. lncRNome genome.igib.res.in/lncRNome
 11. lncRNAtor  http://lncrnator.ewha.ac.kr/index.htm
 12. Noncode v3.0 noncode.org/NONCODERv3
 13. the Functional lncRNA Database www.valadkhanlab.org
 14. UCSC  genome.ucsc.edu
resolved with the complete mastery of bioinformatics 
science (Liew, Yan & Yang 2005). Herewith, as more 
sophisticated pattern recognition methods are in place, the 
jobs for extracting meaningful transcriptomics fingerprint 
will become more feasible (da Sacco, Baldassarre & 
Masotti 2012).
BIOINFORMATICS RESOURCES
Several websites-based bioinformatics resources are 
available to researchers for lncRNA research. They 
contain multiple repositories, databases, softwares, and 
other annotation tools. Bioinformatics databases that 
based on websites is revealed through this Table 5.
All databases that provide information about 
lncRNAs can identify human. Some of them include 
specific information towards rat (lncRNAdb, DIANA-
lncBase, Functional lncRNA Database, Noncode 
v3.0, CHIPBase), also specific towards another model 
organisms (lncRNAdb, CHIPBase, Functional lncRNA 
Database, and DIANA-lncBase). Especially, lncRNAdb and 
Noncode v3.0 databases include lncRNAs that express in 
some species, from yeasts to plants. This databases offer 
information about specific characterization of lncRNAs 
cells or tissues: lncRNAdb, lncRNome, CHIPBase, 
Noncode v3.0, and DIANALncBase. Only Noncode v3.0 
and lncRNAdb localize lncRNAs cellular (Fritah, Niclou 
& Azuaje 2014).
There are different bioinformatics tools for predicting 
the functions and structures of RNA sequences, including 
some tools that concatenate other experimental data in 
the analysis. Moreover, remembering that the recent 
experimental exploratory methods are still restricted in 
their throughput and output, quick bioinformatics tools 
to recognize and characterize lncRNAs with reasonable 
preciseness are needed (Iwakiri, Hamada & Asai 2016). 
Below we evince the available bioinformatics 
databases and tools which beneficial for discovering 
long non-coding RNAs and analyzing their secondary 
structures, conservation, interactions, co-expressions, 
and subcellular localization through Table 6.
SUMMARY
We have expounded multiperspectives of lncRNAs 
comprehensively based on CONDBITs perspectives, i.e.: 
cardiology, oncology, neurology and neuroscience, 
dermatology, the biology of molecular and bioinformatics, 
immunology, and technologies. The CONDBITs perspectives 
could be seen in the Table 7 below. 
ACKNOWLEDGEMENT
The authors would like to thanks to the leaders of Research 
and CSR Institute (LPPM) of Indonesia International Institute 
for Life Sciences (i3L) and University of Muhammadyah 
Makassar for their heartfelt support toward the completion 
of this manuscript. We also thank Prof. Dr. Sofia Mubarika 
for comments on earlier versions of this manuscript. 
8TABLE 6. The explanation on bioinformatics database
 No.                         Bioinformatics Databases/Tools                                        References
 1. NGS (next-generation sequencing) technologies or tiling  (Iwakiri, Hamada & Asai 2016)
  microarrays
 2. LAST, Tophat, STAR (Kim et al. 2013; Kiełbasa et al. 2011; 
   Dobin et al. 2013)
 3. BLASTX (Gish & States 1993)
 4. PORTRAIT, CPC (Cording-Potential Calculator) (Kong et al. 2007; Wang et al. 2013)
 5. RNAcode, PhyloCSF (Washietl et al. 2011; Lin, Jungreis & 
   Kellis 2011)
 6. QRNA, RNAz (Rivas & Eddy 2001; Gruber et al. 2010)
 7. Expression Atlas (Petryszak et al. 2014; Uhlén et al. 2015; 
   Klijn et al. 2015)
 8. ROKU (Kadota et al. 2006)
 9. ENCODE project (Djebali et al. 2012)
 10. HITS-CLIP, PAR-CLIP, RAP-RNA, RIA-seq (Licatalosi et al. 2008; Hafner et al. 2010; 
   Engreitz et al. 2014; Kretz et al. 2013)
 11. IntaRNA (Busch, Richter & Backofen 2008)
 12. CopraRNA (Wright et al. 2013)
 13. A computational pipeline including multiple computational (Frith, Hamada & Horton 2010; Kato et al. 2010; 
  sequence analysis devices (IntaRNA, LAST, RactIP,  Kiryu et al. 2011; Frith 2011)
  Raccess, and TanTan) 
 14. RPI-Pred (Suresh et al. 2015)
 15. catRAPID, RPI-seq, lncPRO (Bellucci et al. 2011; Muppirala, Honavar & 
   Dobbs 2011; Lu et al. 2013)
 16. Machine learning approaches, e.g.: support vector machine  (Pancaldi & Bähler 2011)
  (SVM), Fisher’s LDA (linear discriminant analysis), SVM 
  (support vector machine), and RF (random forest)
 17. Mfold, CentroidFold, RNAfold, and RNAstructure (Sato et al. 2009; Hamada, Kiryu, et al. 2009;
   Zuker 2003; Lorenz et al. 2011; 
   Mathews 2014b, 2014a)
 18. CentroidHomfold (Hamada et al. 2011)
 19. DMS-seq, FragSeq, MAP-seq, Mod-seq, PARS, SHAPE-seq (Rouskin et al. 2014; Ding et al. 2014; 
   Underwood et al. 2010; Seetin et al. 2014; 
   Talkish et al. 2014; Y. Wan et al. 2014; 
   Loughrey et al. 2014)
 20. RNAalifold and Centroid Alifold  (Bernhart et al. 2008; Hamada, Sato & Asai 2011;
   Hamada 2015)
 21. ProbCons (Do et al. 2005)
 22. CentroidAlign, LARA, LocARNA, MAFFT, MXSCARNA (Hamada, Sato, et al. 2009; Bauer, Klau & 
   Reinert 2007; Will et al. 2012; Katoh & Toh 2008;
    Tabei et al. 2008)
 23. PETcofold (Seemann et al. 2011)
 24. Raccess (Kiryu et al. 2011)
 25. Rchange (Kiryu & Asai 2012)
 26. MEMERIS and RNAcontext (Hiller et al. 2006; Kazan et al. 2010)
 27. PLEK (predictor of long non-coding RNAs and messenger (Zhang & Zhou 2014)
  RNAs based on an improved k-mer scheme)
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